This was demonstrated by Heysieattalab et al. [94], who showed that a high dose of delphinidin reduced acetylcholinesterase, amyloid precursor protein (APP), and amyloid beta protein (Aβ) levels in an Alzheimer’s disease model. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.